Literature DB >> 19050283

Adenosine 5'-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype.

Duygu Sag1, David Carling, Robert D Stout, Jill Suttles.   

Abstract

Herein, we demonstrate a role of AMP-activated protein kinase (AMPK) as a potent counterregulator of inflammatory signaling pathways in macrophages. Stimulation of macrophages with anti-inflammatory cytokines (i.e., IL-10 and TGFbeta) resulted in the rapid phosphorylation/activation of AMPK, whereas stimulation of macrophages with a proinflammatory stimulus (LPS) resulted in AMPK dephosphorylation/inactivation. Inhibition of AMPKalpha expression by RNA interference dramatically increased the mRNA levels of LPS-induced TNF-alpha, IL-6, and cyclooxygenase-2. Likewise, expression of a dominant negative AMPKalpha1 in macrophages enhanced TNF-alpha and IL-6 protein synthesis in response to LPS stimulation, while diminishing the production of IL-10. In contrast, transfection of macrophages with a constitutively active form of AMPKalpha1 resulted in decreased LPS-induced TNF-alpha and IL-6 production, and heightened production of IL-10. In addition, we found that AMPK negatively regulated LPS-induced IkappaB-alpha degradation and positively regulated Akt activation, accompanied by inhibition of glycogen synthase kinase beta and activation of CREB. Thus, AMPK directs signaling pathways in macrophages in a manner that suppresses proinflammatory responses and promotes macrophage polarization to an anti-inflammatory functional phenotype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19050283      PMCID: PMC2756051          DOI: 10.4049/jimmunol.181.12.8633

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo.

Authors:  Stephanie K Watkins; Nejat K Egilmez; Jill Suttles; Robert D Stout
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

2.  Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals.

Authors:  Alexei Gratchev; Julia Kzhyshkowska; Kirsten Köthe; Isabelle Muller-Molinet; Sheila Kannookadan; Jochen Utikal; Sergij Goerdt
Journal:  Immunobiology       Date:  2006-07-21       Impact factor: 3.144

Review 3.  AMP-activated protein kinase in metabolic control and insulin signaling.

Authors:  Mhairi C Towler; D Grahame Hardie
Journal:  Circ Res       Date:  2007-02-16       Impact factor: 17.367

Review 4.  The two TORCs and Akt.

Authors:  Prashanth T Bhaskar; Nissim Hay
Journal:  Dev Cell       Date:  2007-04       Impact factor: 12.270

5.  Differential regulation of chemokine production by Fcgamma receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, Type 2).

Authors:  Marina Sironi; Fernando O Martinez; Daniele D'Ambrosio; Marco Gattorno; Nadia Polentarutti; Massimo Locati; Andrea Gregorio; Andrea Iellem; Marco A Cassatella; Jo Van Damme; Silvano Sozzani; Alberto Martini; Francesco Sinigaglia; Annunciata Vecchi; Alberto Mantovani
Journal:  J Leukoc Biol       Date:  2006-05-30       Impact factor: 4.962

6.  Deficiency of fatty acid-binding proteins in mice confers protection from development of experimental autoimmune encephalomyelitis.

Authors:  Joseph M Reynolds; Qiaohong Liu; Katherine C Brittingham; Yawei Liu; Michael Gruenthal; Cem Z Gorgun; Gökhan S Hotamisligil; Robert D Stout; Jill Suttles
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

7.  PPARalpha activators upregulate eNOS activity and inhibit cytokine-induced NF-kappaB activation through AMP-activated protein kinase activation.

Authors:  Toshie Okayasu; Atsuko Tomizawa; Kunihiro Suzuki; Ken-ichi Manaka; Yoshiyuki Hattori
Journal:  Life Sci       Date:  2008-02-16       Impact factor: 5.037

8.  AMP-activated protein kinase phosphorylates transcription factors of the CREB family.

Authors:  D M Thomson; S T Herway; N Fillmore; H Kim; J D Brown; J R Barrow; W W Winder
Journal:  J Appl Physiol (1985)       Date:  2007-12-06

9.  Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 5-aminoimidazole-4-carboxamide riboside is independent of AMP-activated protein kinase.

Authors:  Chih-Lin Kuo; Feng-Ming Ho; Mei Ying Chang; Ekambaranellore Prakash; Wan-Wan Lin
Journal:  J Cell Biochem       Date:  2008-02-15       Impact factor: 4.429

10.  Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade.

Authors:  Matthew J Sanders; Pascal O Grondin; Bronwyn D Hegarty; Michael A Snowden; David Carling
Journal:  Biochem J       Date:  2007-04-01       Impact factor: 3.857

View more
  283 in total

1.  AMP-activated protein kinase suppresses urate crystal-induced inflammation and transduces colchicine effects in macrophages.

Authors:  Yun Wang; Benoit Viollet; Robert Terkeltaub; Ru Liu-Bryan
Journal:  Ann Rheum Dis       Date:  2014-10-31       Impact factor: 19.103

2.  The liver kinase B1 is a central regulator of T cell development, activation, and metabolism.

Authors:  Nancie J MacIver; Julianna Blagih; Donte C Saucillo; Luciana Tonelli; Takla Griss; Jeffrey C Rathmell; Russell G Jones
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

3.  CCAAT-enhancer-binding protein-beta expression in vivo is associated with muscle strength.

Authors:  Lorna W Harries; Luke C Pilling; L Dena G Hernandez; Rachel Bradley-Smith; William Henley; Andrew B Singleton; Jack M Guralnik; Stefania Bandinelli; Luigi Ferrucci; David Melzer
Journal:  Aging Cell       Date:  2012-01-13       Impact factor: 9.304

Review 4.  Modifying radiation damage.

Authors:  Kwanghee Kim; William H McBride
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

Review 5.  Calcium/calmodulin-dependent protein kinase kinase 2: roles in signaling and pathophysiology.

Authors:  Luigi Racioppi; Anthony R Means
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

6.  Myeloid cell-specific disruption of Period1 and Period2 exacerbates diet-induced inflammation and insulin resistance.

Authors:  Hang Xu; Honggui Li; Shih-Lung Woo; Sam-Moon Kim; Vikram R Shende; Nichole Neuendorff; Xin Guo; Ting Guo; Ting Qi; Ya Pei; Yan Zhao; Xiang Hu; Jiajia Zhao; Lili Chen; Lulu Chen; Jun-Yuan Ji; Robert C Alaniz; David J Earnest; Chaodong Wu
Journal:  J Biol Chem       Date:  2014-04-25       Impact factor: 5.157

Review 7.  Metabolism of inflammation limited by AMPK and pseudo-starvation.

Authors:  Luke A J O'Neill; D Grahame Hardie
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

8.  AMP-activated protein kinase activation by 5-aminoimidazole-4-carbox-amide-1-β-D-ribofuranoside (AICAR) reduces lipoteichoic acid-induced lung inflammation.

Authors:  Arie J Hoogendijk; Sandra S Pinhanços; Tom van der Poll; Catharina W Wieland
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

9.  Dietary curcumin supplementation does not alter peripheral blood mononuclear cell responses to exertional heat stress.

Authors:  Peter A Falgiano; Trevor L Gillum; Zach J Schall; Harrison R Strag; Matthew R Kuennen
Journal:  Eur J Appl Physiol       Date:  2018-10-01       Impact factor: 3.078

10.  Activation of AMPK enhances neutrophil chemotaxis and bacterial killing.

Authors:  Dae Won Park; Shaoning Jiang; Jean-Marc Tadie; William S Stigler; Yong Gao; Jessy Deshane; Edward Abraham; Jaroslaw W Zmijewski
Journal:  Mol Med       Date:  2013-11-08       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.